R1 RCM (NASDAQ:RCM) Posts Quarterly Earnings Results, Misses Estimates By $0.04 EPS

R1 RCM (NASDAQ:RCM) released its quarterly earnings data on Tuesday. The healthcare provider reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.04), Briefing.com reports. R1 RCM had a negative net margin of 1.68% and a negative return on equity of 1.44%. The company had revenue of $656.80 million for the quarter, compared to analysts’ expectations of $640.93 million. R1 RCM’s revenue for the quarter was up 14.7% compared to the same quarter last year.

R1 RCM Price Performance

NASDAQ RCM remained flat at $14.27 during trading on Wednesday. 1,362,472 shares of the company’s stock were exchanged, compared to its average volume of 3,480,023. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.84 and a current ratio of 1.84. The stock has a market cap of $6.02 billion, a price-to-earnings ratio of -142.70 and a beta of 0.84. The company has a 50-day simple moving average of $14.18 and a 200 day simple moving average of $13.28. R1 RCM has a 1-year low of $8.87 and a 1-year high of $15.12.

Analyst Ratings Changes

A number of analysts have commented on the stock. Canaccord Genuity Group reaffirmed a “buy” rating and set a $15.00 target price on shares of R1 RCM in a report on Monday, July 22nd. TD Cowen reaffirmed a “hold” rating and set a $14.30 target price (down from $20.00) on shares of R1 RCM in a report on Monday, August 5th. Truist Financial reduced their target price on shares of R1 RCM from $16.00 to $14.30 and set a “hold” rating for the company in a report on Thursday, August 8th. Jefferies Financial Group cut shares of R1 RCM from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Finally, Leerink Partners cut shares of R1 RCM from an “outperform” rating to a “market perform” rating and reduced their price objective for the stock from $17.00 to $14.30 in a research note on Thursday, August 1st. Thirteen research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $15.41.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.